Biodesix GAAP EPS of -$0.49 beats by $0.38, revenue of $28.7M beats by $2.45M
Source: SeekingAlpha
2026-02-26 17:04:50 ET
More on Biodesix
- Biodesix skyrockets 43%, expects FY revenue to beat guidance
- Seeking Alpha’s Quant Rating on Biodesix
- Historical earnings data for Biodesix
- Financial information for Biodesix
Read the full article on Seeking Alpha
For further details see:
Biodesix GAAP EPS of -$0.49 beats by $0.38, revenue of $28.7M beats by $2.45M
Biodesix Inc.
NASDAQ: BDSX
BDSX Trading
-0.5% G/L:
$18.89 Last:
7,624 Volume:
$18.51 Open:
BDSX Latest News
February 26, 2026 04:01:00 pm
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
BDSX Stock Data
$83,296,022
3,850,552
19.65%
10
N/A
Medical Diagnostics & Screening
Healthcare
US
Louisville
